DEFA14A: Sutro Biopharma Corrects Stockholder Proposal Deadline for 2025 Annual Meeting

Sutro Biopharma issued a supplement to its proxy statement to correct a typographical error regarding the deadline for stockholders to submit proposals for the 2025 annual meeting.

Summary

• Sutro Biopharma has filed a supplement to its proxy statement dated April 26, 2024, to correct a typographical error.
• The correction pertains to the deadline for stockholders to submit notices for proposals to be brought before the company's 2025 Annual Meeting.
• The corrected deadline for stockholder notices is between 5:00 p.m. Eastern Time on February 6, 2025, and 5:00 p.m. Eastern Time on March 8, 2025.
• If the date of the 2025 Annual Meeting is more than 30 days before or more than 70 days after the one-year anniversary of the 2024 Annual Meeting, different deadlines apply.
• Stockholder proposals submitted under Rule 14a-8 for inclusion in the proxy materials must be received by December 27, 2024.

Sentiment

Score: 7

Explanation: The document is a neutral correction of a procedural detail, indicating attention to accuracy and compliance.

Positives

• The company is proactively correcting an error in its proxy statement to ensure stockholders have accurate information.

Future Outlook

The document outlines the requirements and deadlines for stockholders to submit proposals for the 2025 Annual Meeting.

Industry Context

This announcement is a routine update related to corporate governance and shareholder engagement, which is standard practice for publicly traded companies.

Stakeholder Impact

• Ensures shareholders are aware of the correct deadlines for submitting proposals.

Next Steps

• Stockholders intending to submit proposals for the 2025 Annual Meeting should adhere to the corrected deadlines and requirements outlined in the supplement.

Key Dates

Keywords

stockholder proposals, annual meeting, proxy statement, Sutro Biopharma, deadline, notice